🇨🇭 Switzerland Country × Condition
acute myeloid leukemia Clinical Trials in Switzerland
Active clinical trials for acute myeloid leukemia with research sites in Switzerland. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 1, Phase 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇨🇭 Switzerland
Active Trials in Switzerland (2)
NCT03828773
Recruiting
PTX3-targeted Antifungal Prophylaxis
Enrollment
410 pts
Country
🇨🇭 Switzerland
Bochud Pierre-Yves
View Trial → NCT03300492 Phase 1, Phase 2
Recruiting
Expanded Natural Killer Cells Following Haploidentical HSCT for AML/MDS
Enrollment
10 pts
Country
🇨🇭 Switzerland
University Hospital, Basel, Switzer...
View Trial → Frequently Asked Questions
How many acute myeloid leukemia clinical trials are active in Switzerland?
There are currently 2 active clinical trials for acute myeloid leukemia with sites in Switzerland, of which 2 are actively recruiting patients.
How can I join a acute myeloid leukemia clinical trial in Switzerland?
To join a acute myeloid leukemia clinical trial in Switzerland, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Switzerland directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are acute myeloid leukemia trials in Switzerland?
Active acute myeloid leukemia trials in Switzerland span Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology